Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Ventricular Assist Device Market?

The market size for ventricular assist devices has experienced a swift increase in recent years. Projected to expand from $2.12 billion in 2024 to $2.39 billion in 2025, it boasts a compound annual growth rate (CAGR) of 12.6%. This significant growth during the historical period can be linked to the escalating frequency of heart failure cases, alongside an increased demand for organ transplant procedures.

What Growth Rate Is Forecasted for the Ventricular Assist Device Market by 2029?

In the coming years, the ventricular assist device market is anticipated to witness significant growth and expand to a value of $3.91 billion by 2029 with a compound annual growth rate (CAGR) of 13.1%. Several factors have been identified that will contribute to this suggested growth during the forecast period, including a growing demand for destination therapy, an aging global population, increased spending on healthcare, and a heightened understanding and awareness of heart failure treatments. Furthermore, a number of emerging trends are expected to shape the market during this period, such as enhancing the durable lifespan of VADs, downsizing of VADs, advancements in pump technologies, an emphasis on the safety and effectiveness of VADs, efforts to reduce VAD-related complications, and the use of ventricular assist devices inserted through the skin.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

Which Key Companies Are Shaping the Future of the Ventricular Assist Device Market?

Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Which Factors Are Driving Demand in the Ventricular Assist Device Industry?

The escalation of heart-related conditions is one of the main drivers propelling the growth of the ventricular assist device market. Cardiovascular disorders, which are triggered by elevated blood pressure, smoking, elevated cholesterol levels, lack of physical activity, among other risk factors, have been on the rise. Noncontagious diseases like diabetes, chronic respiratory diseases, and hypertension-induced heart attacks also contribute to the rise of these disorders. As the number of cardiovascular disorders surge, so does the demand for ventricular assist devices, which serve as a lifeline for patients with severe cardiac conditions. The National Library of Medicine, a federal agency based in the United States, stated in October 2022 that by 2035, it is estimated that 45.1% of the American population will suffer from some form of cardiovascular disease. The overall expenses associated with these disorders are predicted to hit $1.1 trillion by 2035. Consequently, the increasing incidence of cardiovascular disorders is poised to spur the demand for ventricular assist devices in the anticipated period.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

How Is the Ventricular Assist Device Market Segmented by Several Divisions?

The ventricular assist device market covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

What are the Emerging Market Trends Driving the Growth of the Ventricular Assist Device Industry?

Ventricular assist devices that are inserted percutaneously are gaining traction in the market. This non-pulsatile axial flow pump, situated across the aortic valve, works by pumping blood from the left ventricle. The use of a percutaneously inserted VAD can effectively reduce the load on the left ventricle, as well as decrease myocardial oxygen consumption. This enhances cardiac output and minimizes left ventricular end-diastolic pressure. For instance, Impella, a percutaneous VAD developed by Abiomed Inc., a medical device company based in the US, was made available for suitable pediatric patients in the USA in August 2022. The device effectively provides adequate cardiac support for patients with a malfunctioned left ventricle. It’s also capable of replacing extracorporeal membrane oxygenation (ECMO) or being used alongside it to enhance hemodynamics.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Which Regions Are Driving Growth in the Ventricular Assist Device Market?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6680

This Report Delivers Insight On:

1. How big is the ventricular assist device market, and how is it changing globally?

2. Who are the major companies in the ventricular assist device market, and how are they performing?

3. What are the key opportunities and risks in the ventricular assist device market right now?

4. Which products or customer segments are growing the most in the ventricular assist device market?

5. What factors are helping or slowing down the growth of the ventricular assist device market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model